Effectiveness of the Prostate-specific Antigen test – Journal Club

Journal Clubs like ours play a vital role in the medical community. They provide a platform for sharing recent research, discussing new ideas, and critically evaluating clinical practices. These sessions foster continuous learning and collaboration, which is essential for advancing medical knowledge and improving patient care.

Recently, at the Journal Club of STAP, I had the opportunity to present a significant topic: “A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer” This presentation was based on a multicenter randomized prospective study examining the effectiveness of the PSA test.

Prostate cancer is a major health issue, and PSA testing has been a key tool in its early detection. However, there’s ongoing debate about its necessity and effectiveness. The study I discussed evaluated how well PSA testing identifies prostate cancer early and improves patient survival rates.

Our discussion on PSA testing in prostate cancer screening is a prime example of how these meetings can enhance our understanding and inform better healthcare decisions. It was a great experience to share and discuss this important topic with peers, enhancing our collective understanding and approach to patient care.

Guest Author: Ahmet Burak Yilmaz, MD

Graduated from Gülhane Faculty of Medicine in 2018. Has been working as a physician for five years. Currently working as a Urology resident at Ankara City Hospital. Loves exercising and spending time with his cats.